127 related articles for article (PubMed ID: 12591136)
1. The cholinesterase inhibitor DFP facilitates the expression of paradoxical sleep (PS) propensity in rats subjected to short-term PS deprivation.
Deurveilher S; Hennevin E
Brain Res; 2003 Mar; 965(1-2):180-6. PubMed ID: 12591136
[TBL] [Abstract][Full Text] [Related]
2. Chronic, low-level exposure to the cholinesterase inhibitor DFP. II. Time course of behavioral state changes in rats.
Deurveilher S; Hars B; Hennevin E
Pharmacol Biochem Behav; 1999 Sep; 64(1):105-14. PubMed ID: 10495004
[TBL] [Abstract][Full Text] [Related]
3. Lesions of the pedunculopontine tegmental nucleus reduce paradoxical sleep (PS) propensity: evidence from a short-term PS deprivation study in rats.
Deurveilher S; Hennevin E
Eur J Neurosci; 2001 May; 13(10):1963-76. PubMed ID: 11403690
[TBL] [Abstract][Full Text] [Related]
4. The acetylcholinesterase inhibitor di-isopropyl-fluorophosphate increases REM sleep in rats.
Gnadt JW; Pegram GV; Baxter JF
Physiol Behav; 1985 Dec; 35(6):911-6. PubMed ID: 4095183
[TBL] [Abstract][Full Text] [Related]
5. Chronic stress during paradoxical sleep deprivation increases paradoxical sleep rebound: association with prolactin plasma levels and brain serotonin content.
Machado RB; Tufik S; Suchecki D
Psychoneuroendocrinology; 2008 Oct; 33(9):1211-24. PubMed ID: 18674865
[TBL] [Abstract][Full Text] [Related]
6. Chronic, low-level exposure to the cholinesterase inhibitor DFP. I. Time course of neurochemical changes in the rat pontomesencephalic tegmentum.
Deurveilher S; Delamanche IS; Hars B; Breton P; Hennevin E
Pharmacol Biochem Behav; 1999 Sep; 64(1):95-103. PubMed ID: 10495003
[TBL] [Abstract][Full Text] [Related]
7. Effects of cholinesterase inhibitors on evoked responses in field CA1 of the rat hippocampus.
Williamson AM; Sarvey JM
J Pharmacol Exp Ther; 1985 Nov; 235(2):448-55. PubMed ID: 4057081
[TBL] [Abstract][Full Text] [Related]
8. Effects of sleep loss on sleep architecture in Wistar rats: gender-specific rebound sleep.
Andersen ML; Antunes IB; Silva A; Alvarenga TA; Baracat EC; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):975-83. PubMed ID: 18276051
[TBL] [Abstract][Full Text] [Related]
9. Effect of paradoxical sleep deprivation on vasoactive intestinal peptide-like immunoreactivity in discrete brain areas and anterior pituitary of the rat.
Morin AJ; Denoroy L; Jouvet M
Brain Res Bull; 1992 May; 28(5):655-61. PubMed ID: 1617452
[TBL] [Abstract][Full Text] [Related]
10. Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning.
Prendergast MA; Terry AV; Buccafusco JJ
Psychopharmacology (Berl); 1997 Jan; 129(2):183-91. PubMed ID: 9040125
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical sleep-promoting effects of brain extract from paradoxical sleep-deprived rats.
Wetzel W; Schmidt U; Wagner T; Matthies H
Brain Res Bull; 1990 Jun; 24(6):743-6. PubMed ID: 2372693
[TBL] [Abstract][Full Text] [Related]
12. Influence of paradoxical sleep deprivation on the intermediate stage of sleep in the rat.
Gandolfo G; Gauthier P; Arnaud C; Gottesmann C
Neurosci Res; 1996 Jun; 25(2):123-7. PubMed ID: 8829148
[TBL] [Abstract][Full Text] [Related]
13. Dorsoventral-Specific Effects of Nerve Agent Surrogate Diisopropylfluorophosphate on Synaptic Transmission in the Mouse Hippocampus.
Brown KA; Filipov NM; Wagner JJ
J Pharmacol Exp Ther; 2020 Apr; 373(1):10-23. PubMed ID: 31907304
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical sleep deprivation and the immobility response in the rat: effects of desipramine and phentolamine.
van Luijtelaar EL; Coenen AM
Sleep; 1985; 8(1):49-55. PubMed ID: 3992109
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic modulation of inhibitory avoidance impairment induced by paradoxical sleep deprivation.
Bueno OF; Oliveira GM; Lobo LL; Morais PR; Melo FH; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2000 May; 24(4):595-606. PubMed ID: 10958153
[TBL] [Abstract][Full Text] [Related]
16. Effects of paradoxical sleep deprivation in the rabbit.
Pivik RT; Bylsma FW; Cooper P
Physiol Behav; 1986; 36(4):671-6. PubMed ID: 3714840
[TBL] [Abstract][Full Text] [Related]
17. Effects of diisopropylfluorophosphate on brain cholinergic systems of rats at early developmental stages.
Michalek H; Pintor A; Fortuna S; Bisso GM
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S204-12. PubMed ID: 4092888
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor (CRF) increases paradoxical sleep (PS) rebound in PS-deprived rats.
Marrosu F; Gessa GL; Giagheddu M; Fratta W
Brain Res; 1990 May; 515(1-2):315-8. PubMed ID: 2357570
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Toxicol Appl Pharmacol; 1990 Nov; 106(2):295-310. PubMed ID: 2256118
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological analysis of diisopropyl fluorophosphate: effects on core temperature, heart rate, and motor activity in the unrestrained rat.
Gordon CJ
Pharmacol Biochem Behav; 1996 Oct; 55(2):185-94. PubMed ID: 8951953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
